LifECORE BIOMEDICAL INC(简称Lifecore)近日宣布与Indomo达成一项全新合作协议,旨在支持开发一种结合药物与器械的创新性痤疮治疗方案。此次合作将整合双方在生物材料与医疗器械领域的专长,有望为痤疮患者提供更高效、便捷的治疗选择。
该药物器械组合疗法预计将利用Lifecore在生物医药材料方面的技术积累,结合Indomo在设备设计上的创新能力,打造差异化的治疗方案。
LifECORE BIOMEDICAL INC(简称Lifecore)近日宣布与Indomo达成一项全新合作协议,旨在支持开发一种结合药物与器械的创新性痤疮治疗方案。此次合作将整合双方在生物材料与医疗器械领域的专长,有望为痤疮患者提供更高效、便捷的治疗选择。
该药物器械组合疗法预计将利用Lifecore在生物医药材料方面的技术积累,结合Indomo在设备设计上的创新能力,打造差异化的治疗方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.